Eunice S. Wang, MD, highlights the importance of biomarkers and MRD testing for optimal treatment of patients with AML.
Amir Fathi, MD, provides expert insights and guidance on the best strategies to optimize treatment for patients with FLT3-mutant or IDH-mutant AML.
Jeffrey E. Lancet, MD, provides expert insights and guidance on the best strategies to treat elderly and other patients with newly diagnosed AML.
Farhad Ravandi, MD, examines current and investigational AML treatment approaches using antibody-drug conjugates and other immunotherapies.
Download this PDF guide to best practices for the management of patients with acute myeloid leukemia.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.